Organogenesis Holdings Inc. current report, 09 May 2024

Business Context and Reporting Period

Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 9, 2024
Reporting Period: Fiscal First Quarter ended March 31, 2024

This filing serves as a notification that the Company announced its financial results for the first quarter of fiscal 2024 via a press release dated May 9, 2024. The detailed results are incorporated by reference as Exhibit 99.1.

Key Financial Metrics

The provided text is a cover sheet for the 8-K filing and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.

Source data does not provide clear values for financial metrics in this document.

Material Changes

No material changes versus the prior comparable period are detailed in this specific filing text. The document solely references the announcement of the Q1 2024 results.

Guidance, Outlook, and Risks

Management Commentary: The filing indicates that management has issued a press release regarding Q1 2024 results, but the content of that commentary is not present in this text.
Legal Disclaimer: The information in the attached press release is intended to be "furnished" and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section, except as expressly set forth by specific reference.

Investor Verification Checklist

  • Review the full text of the Press Release dated May 9, 2024 (Exhibit 99.1) for specific Q1 2024 revenue and earnings figures.
  • Verify the Company's liquidity position and cash flow details in the referenced press release or subsequent 10-Q filing.
  • Confirm any forward-looking statements or guidance provided in the press release, noting the legal distinction that the 8-K itself does not "file" this information under Section 18.
  • Check for any unusual items or contingencies disclosed in the full press release that may impact future performance.